475 related articles for article (PubMed ID: 17620607)
1. Aristolochic acid and the etiology of endemic (Balkan) nephropathy.
Grollman AP; Shibutani S; Moriya M; Miller F; Wu L; Moll U; Suzuki N; Fernandes A; Rosenquist T; Medverec Z; Jakovina K; Brdar B; Slade N; Turesky RJ; Goodenough AK; Rieger R; Vukelić M; Jelaković B
Proc Natl Acad Sci U S A; 2007 Jul; 104(29):12129-34. PubMed ID: 17620607
[TBL] [Abstract][Full Text] [Related]
2. Aristolactam-DNA adducts are a biomarker of environmental exposure to aristolochic acid.
Jelaković B; Karanović S; Vuković-Lela I; Miller F; Edwards KL; Nikolić J; Tomić K; Slade N; Brdar B; Turesky RJ; Stipančić Ž; Dittrich D; Grollman AP; Dickman KG
Kidney Int; 2012 Mar; 81(6):559-67. PubMed ID: 22071594
[TBL] [Abstract][Full Text] [Related]
3. p53 mutations as fingerprints for aristolochic acid: an environmental carcinogen in endemic (Balkan) nephropathy.
Slade N; Moll UM; Brdar B; Zorić A; Jelaković B
Mutat Res; 2009 Apr; 663(1-2):1-6. PubMed ID: 19428366
[TBL] [Abstract][Full Text] [Related]
4. Evidence of exposure to aristolochic acid in patients with urothelial cancer from a Balkan endemic nephropathy region of Romania.
Schmeiser HH; Kucab JE; Arlt VM; Phillips DH; Hollstein M; Gluhovschi G; Gluhovschi C; Modilca M; Daminescu L; Petrica L; Velciov S
Environ Mol Mutagen; 2012 Oct; 53(8):636-41. PubMed ID: 22987305
[TBL] [Abstract][Full Text] [Related]
5. Exceptionally long-term persistence of DNA adducts formed by carcinogenic aristolochic acid I in renal tissue from patients with aristolochic acid nephropathy.
Schmeiser HH; Nortier JL; Singh R; Gamboa da Costa G; Sennesael J; Cassuto-Viguier E; Ambrosetti D; Rorive S; Pozdzik A; Phillips DH; Stiborova M; Arlt VM
Int J Cancer; 2014 Jul; 135(2):502-7. PubMed ID: 24921086
[TBL] [Abstract][Full Text] [Related]
6. Role of environmental toxins in endemic (Balkan) nephropathy. October 2006, Zagreb, Croatia.
Grollman AP; Jelaković B
J Am Soc Nephrol; 2007 Nov; 18(11):2817-23. PubMed ID: 17942951
[TBL] [Abstract][Full Text] [Related]
7. Analysis of TP53 mutation spectra reveals the fingerprint of the potent environmental carcinogen, aristolochic acid.
Hollstein M; Moriya M; Grollman AP; Olivier M
Mutat Res; 2013; 753(1):41-49. PubMed ID: 23422071
[TBL] [Abstract][Full Text] [Related]
8. Aristolochic acid nephropathy: Harbinger of a global iatrogenic disease.
Grollman AP
Environ Mol Mutagen; 2013 Jan; 54(1):1-7. PubMed ID: 23238808
[TBL] [Abstract][Full Text] [Related]
9. Balkan Endemic Nephropathy and the Causative Role of Aristolochic Acid.
Jelaković B; Dika Ž; Arlt VM; Stiborova M; Pavlović NM; Nikolić J; Colet JM; Vanherweghem JL; Nortier JL
Semin Nephrol; 2019 May; 39(3):284-296. PubMed ID: 31054628
[TBL] [Abstract][Full Text] [Related]
10. Biomonitoring of aristolactam-DNA adducts in human tissues using ultra-performance liquid chromatography/ion-trap mass spectrometry.
Yun BH; Rosenquist TA; Sidorenko V; Iden CR; Chen CH; Pu YS; Bonala R; Johnson F; Dickman KG; Grollman AP; Turesky RJ
Chem Res Toxicol; 2012 May; 25(5):1119-31. PubMed ID: 22515372
[TBL] [Abstract][Full Text] [Related]
11. Variation in presentation and presence of DNA adducts and p53 mutations in patients with endemic nephropathy--an environmental form of the aristolochic acid nephropathy.
Karanović S; Lela IV; Jelaković B; Dickman KG; Peić AK; Dittrich D; Knežević M; Matijević V; Fernandes AS; Miller F
Kidney Blood Press Res; 2013; 37(1):1-8. PubMed ID: 23445829
[TBL] [Abstract][Full Text] [Related]
12. Chinese herbs nephropathy and Balkan endemic nephropathy: toward a single entity, aristolochic acid nephropathy.
De Broe ME
Kidney Int; 2012 Mar; 81(6):513-5. PubMed ID: 22373701
[TBL] [Abstract][Full Text] [Related]
13. Aristolochic acid-induced upper tract urothelial carcinoma in Taiwan: clinical characteristics and outcomes.
Chen CH; Dickman KG; Huang CY; Moriya M; Shun CT; Tai HC; Huang KH; Wang SM; Lee YJ; Grollman AP; Pu YS
Int J Cancer; 2013 Jul; 133(1):14-20. PubMed ID: 23292929
[TBL] [Abstract][Full Text] [Related]
14. Aristolochic acid-associated urothelial cancer in Taiwan.
Chen CH; Dickman KG; Moriya M; Zavadil J; Sidorenko VS; Edwards KL; Gnatenko DV; Wu L; Turesky RJ; Wu XR; Pu YS; Grollman AP
Proc Natl Acad Sci U S A; 2012 May; 109(21):8241-6. PubMed ID: 22493262
[TBL] [Abstract][Full Text] [Related]
15. Aristolochic acid mutagenesis: molecular clues to the aetiology of Balkan endemic nephropathy-associated urothelial cancer.
Arlt VM; Stiborová M; vom Brocke J; Simões ML; Lord GM; Nortier JL; Hollstein M; Phillips DH; Schmeiser HH
Carcinogenesis; 2007 Nov; 28(11):2253-61. PubMed ID: 17434925
[TBL] [Abstract][Full Text] [Related]
16. New molecular and field evidences for the implication of mycotoxins but not aristolochic acid in human nephropathy and urinary tract tumor.
Pfohl-Leszkowicz A; Tozlovanu M; Manderville R; Peraica M; Castegnaro M; Stefanovic V
Mol Nutr Food Res; 2007 Sep; 51(9):1131-46. PubMed ID: 17729220
[TBL] [Abstract][Full Text] [Related]
17. Balkan endemic nephropathy: an update on its aetiology.
Stiborová M; Arlt VM; Schmeiser HH
Arch Toxicol; 2016 Nov; 90(11):2595-2615. PubMed ID: 27538407
[TBL] [Abstract][Full Text] [Related]
18. Urothelial carcinoma associated with Balkan endemic nephropathy. A worldwide disease.
Stefanovic V; Polenakovic M; Toncheva D
Pathol Biol (Paris); 2011 Oct; 59(5):286-91. PubMed ID: 19896305
[TBL] [Abstract][Full Text] [Related]
19. DNA Adducts Formed by Aristolochic Acid Are Unique Biomarkers of Exposure and Explain the Initiation Phase of Upper Urothelial Cancer.
Stiborová M; Arlt VM; Schmeiser HH
Int J Mol Sci; 2017 Oct; 18(10):. PubMed ID: 29036902
[TBL] [Abstract][Full Text] [Related]
20. TP53 Mutational signature for aristolochic acid: an environmental carcinogen.
Moriya M; Slade N; Brdar B; Medverec Z; Tomic K; Jelaković B; Wu L; Truong S; Fernandes A; Grollman AP
Int J Cancer; 2011 Sep; 129(6):1532-6. PubMed ID: 21413016
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
